Kiniksa Pharmaceuticals International, plc KNSA
94.74 USD +1.21 (+1.29%)
As ofNov 20, 2026, 10:47 AM EST
93.73 Day range 95.21
37.02 52-week range 99.31
- YTD
- +129.68%
- 1 year
- +128.35%
Held by funds
139 US ETFs and mutual funds hold KNSA · largest positions
- IWM 0.15% of fund $117.57M
- VTI 0.00% of fund $103.84M
- FSPHX 1.14% of fund $77.59M
- VB 0.04% of fund $73.02M
- FBIOX 0.80% of fund $47.57M
- FIDGX 0.51% of fund $45.70M
- IWO 0.30% of fund $42.66M
- VBK 0.09% of fund $40.65M
- FHCIX 1.11% of fund $37.30M
- FSSNX 0.11% of fund $36.48M
- DFAS 0.09% of fund $31.14M
- FBTTX 1.22% of fund $28.74M
- FDSCX 0.39% of fund $28.59M
- GTSVX 1.68% of fund $23.30M
- VTWO 0.11% of fund $19.81M
- VEXRX 0.08% of fund $18.43M
- FNITX 0.06% of fund $17.41M
- DFAC 0.02% of fund $15.44M
- FFIDX 0.16% of fund $14.74M
- FDSSX 0.11% of fund $12.14M
Ownership
Held by insiders 3.55%
Held by institutions 101.46%
Float held by institutions 105.19%
Institutions 430
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMR, LLC | 18.58% | 7,487,391 | 700.33M | Sep 29, 2026 |
| Blackrock Inc. | 7.30% | 2,943,674 | 275.34M | Sep 29, 2026 |
| Baker Bros. Advisors, LP | 7.03% | 2,834,643 | 265.14M | Sep 29, 2026 |
| Rubric Capital Management LP | 6.98% | 2,813,469 | 263.16M | Sep 29, 2026 |
| Tang Capital Management, LLC | 5.61% | 2,259,889 | 211.38M | Sep 29, 2026 |
| Vanguard Portfolio Management LLC | 5.04% | 2,030,666 | 189.94M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.27% | 1,318,452 | 123.32M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.93% | 1,180,466 | 110.41M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 2.58% | 1,040,000 | 97.28M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.37% | 954,719 | 89.30M | Jun 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 1.89% | 761,824 | 71.26M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.58% | 637,600 | 59.64M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKER BROS ADVISORS L.P. | Unknown | Stock Award(Grant) | May 28, 2026 | 0 |
| BAKER BROTHERS LIFE SCIENCES, L.P. | Director | Stock Award(Grant) | Jun 2, 2025 | 0 |
| LEVY RICHARD S | Director | Conversion of Exercise of derivative security | Jul 30, 2026 | 22,359 |
| MALLEY THOMAS ROBERT | Director | Conversion of Exercise of derivative security | May 28, 2026 | 87,312 |
| MCCAIN TRACEY LORENE | Director | Conversion of Exercise of derivative security | May 28, 2026 | 15,345 |
| PAOLINI JOHN F | Officer | Conversion of Exercise of derivative security | Nov 12, 2026 | 114,048 |
